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1, Introduction 
Different compounds accumulate in body fluids of 
patients with uremia. Those of 350-2000 M, are 
called middle molecules [1,2]. They are assumed to 
exert toxic effects [3]. Many UVabsorbing middle 
molecule fractions can be recovered by gel-fdtration 
followed by ion-exchange chromatography [4]. Some 
of these fractions are heterogeneous [ 51 requiring 
further separation i to individual components. 
One middle molecule fraction, usually very promi- 
nent in severe uremia (peak 7c in [4]) has been iso- 
lated and shown to be a new glycine-containing com- 
pound [6]. We now report the complete structure of 
this middle molecule, showing it to be a double con- 
jugate of o-hydroxybenzoic acid with glycine and 
glucuronic acid. Glucuronides and glycine conjugates 
are constituents of normal urine and of dialysis fluid 
from uremic patients [7-91 but they are presently 
also shown to be combined in a middle molecule. 
2. Materials and methods 
Pre-dialysis ultrafiltrate of plasma from a uremic 
patient on intermittent hemodialysis (urea 29 mmol/l, 
creatinine 1000 pmol/l) was obtained by applying 
negative pressure in the dialysate compartment of a 
Gambro Lundia dialyzer with 13.5 pm cuprophane 
membranes, while no dialysis fluid was running 
through the dialyzer [lo]. 
Fractionation on Sephadex G-l 5 in 0.03 M ammo- 
nium acetate followed by ion-exchange chromatog- 
raphy on DEAE A-25 with increasing ammonium 
acetate concentrations yielded middle molecule frac- 
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tion 7c [4,5]. Analytical isotachophoresis [5] was 
performed on an LKB 2127 Tachophor [Ill, and 
high-performance liquid chromatography (Hewlett 
Packard 1084 B) using a CIs column, in 5 mM sodium 
acetate (pH 4.0) with a gradient of acetonitrile. 
For solvolysis, the sample was dissolved in 1 vol. 
ethanol and 9 vol. ethyl acetate quilibrated with 2 M 
aqueous ulphuric acid and kept at 39’C overnight. 
Alkaline hydrolysis was made with 15% (w/v) NaOH 
in 50% aqueous ethanol for 10 h at 110°C in closed 
steel tubes, partial acid hydrolysis in 10 M HCI for 
18 h at room temperature and enzymatic hydrolysis 
in 5 ml 0.2 M sodium acetate buffer (PH 4.5) with 
10 000 units of /3-glucuronidase (Sigma, type B-10, 
from bovine liver) at 37°C for 24 h. Elemental analy- 
sis was made on a Carlo Erba Elemental Analyzer 
[13-151. 
Gas chromatography-mass spectrometry (GC/MS), 
was carried out on a modified LKB 9000 instrument 
[ 151. Direct inlet probe mass pectra were recorded 
using a modified LKB 2091 mass pectrometer. Sam- 
ples were methylated with diazomethane in diethyl 
ether/methanol (9: 1, v/v). Trimethylsilyl (TMS) 
ethers were then prepared in pyridine/hexamethyl- 
disilazane/trimethylchlorosilane (3:2: 1, by vol.) at 
room temperature for 3-60 min. Reagents were 
removed under nitrogen and the samples were imme- 
diately dissolved in hexane. 
Starting with o-, m- and p-hydroxybenzoic acids 
the corresponding hydroxyhippuric acids were synthe- 
sized by an active ester method using N-hydroxysuc- 
cinimide and dicyclohexylcarbodiimide. UV spectra 
were recorded with a Beckman Model 24 spectro- 
photometer. Melting points were determined with an 
Olympus instrument. 
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3. Results and discussion 
3.1. Initial characterization 
The compound was isolated from a uremic patient 
and had the known structure A-B-Gly [6]. Partial 
acid hydrolysis had been found to cleave the bond 
between A and B but not to liberate glycine. As a fur- 
ther test for homogeneity the substance was analyzed 
by high-performance liquid chromatography before 
and after methylation. As seen in fig.1 the compound 
appeared as a single peak after derivatization. 
3.2. o-Hydroxybenzoic acid as the non-terminal con- 
stituen t (B) 
The initial characterization indicated that the com- 
pound was a double conjugate, partly analogous to a 
sulphated glycine conjugated bile acid. Therefore, a 
method to deconjugate bile acids, involving solvolysis 
and alkaline hydrolysis was employed [ 151. After 
extraction, methylation and silylation, the derivative 
was analyzed by GC/MS. The result indicated the 
presence of o-hydroxyhippuric acid, a conjugate of 
o-hydroxybenzoic acid and glycine (fig.2A). Thus, 
the bond between A and B (B being hydroxybenzoic 
acid) in the formula A-B-Gly was cleaved but not 
that between hydroxybenzoic acid and glycine. 
The identification of hydroxyhippuric acid was 
unequivocal but the ortho-position of the hydroxyl, 
suggested as the most likely anernatrve was not posi- 
Fig.2A. Mass spectrum of the methyl ester TMS ether deriva- 
tive of fraction 7c after solvolysis and alkaline hydrolysis. 
Fig2B. Isotachophoretic separation of: (a) fraction 7c after 
partial hydrolysis; (b) synthetic o-hydroxyhippuric acid; (c) 
mixture of (a) and (b). 
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Fig.1. High-performance liquid chromatography of fraction 7c 
underivatized (left) and methylated (right). The early peak 
complex at -2 min is derived from injection artifacts. The 
underivatized sample gives no resolved peaks. 
tively established. The o-, m- and p-hydroxyhippuric 
acids were therefore synthetized. Spectral properties 
and melting points of the 3 isomers are summarized 
in table 1, and show that the aromatic hydroxyl of 
the investigated middle molecule compound is in the 
ortho-position. This result was confirmed by iso- 
tachophoretic analysis after partial acid hydrolysis. 
Synthetic o-hydroxyhippuric acid was similarly ana- 
lyzed alone and mixed with the partially hydrolyzed 
middle molecule fraction. One of the two zones 
derived from the biological material was identical 
with the single zone from the synthetic o-hydroxy- 
hippuric acid (fig2B). These experiments establish 
that the product released upon partial hydrolysis is 
identical with o-hydroxyhippuric acid, in agreement 
with the result of the GC/MS analysis after alkaline 
hydrolysis. Consequently, B in the initial structure is 
equal to o-hydroxybenzoic acid. 
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Table 1 
Properties of different hydroxyhippuric acid derivatives 
o-OH-hippuric acid 
(commercial) 
o-OH-hippuric acid 
(synthesized) 
m-OH-hippuric acid 
(synthesized) 
p-OH-hippuric acid 
(synthesized) 
Fraction 7c 
(after partial 
hydrolysis) 
Melting UV max (nm) 
point 
(H, 0) CH,OH CH,OH/OH- 
168°C 237,301 328 
168°C 237,301 328 
191°C 292 317 
240°C 254 291 
237,301 
3.3. Glucuronic acid as the third constituent (A) 
To investigate if sulphate or phosphate were con- 
stituents of fraction 7c, elemental nalyses were car- 
ried out. Sulphur and phosphorus were not found but 
considerable amounts of oxygen. This suggested the 
possibility of carbohydrate as a third constituent. The 
A 
Table 2 
Elemental analysis of fraction 7c 
Element Amounts &g) 
recovered 
Calculated amounts 
from formula (fig.3B; 
diammonium salt) 
C 5.50 5.54 
H 0.80 0.71 
0 4.94 4.92 
N 1.22 1.29 
Total 12.46 12.46 
derivatives of glucuronic acid conjugates [ 161 and 
suggested glucuronic acid to be component A. This 
was confirmed by hydrolysis with &lucuronidase, 
which also established the &lycosidic nature of the 
linkage. 
3 4. Complete structure 
The structure of the compound is shown in fig.3B. 
The molecule is a double conjugate of o-hydroxyben- 
zoic acid with glycine and glucuronic acid (M, = 371). 
A role of free and conjugated phenols as uremic 
toxins has been suggested [ 18,191, and some seem to 
exert a toxic effect on Na+-transport [8]. W-absorb- 
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Fig.fA. Mass spectrum of the methyl ester TMS ether derivative of fraction 7c, obtained using the direct inlet probe. 
B 
atomic ratios agreed reasonably well with those from 
the later derived formula. The comparison is shown in 
table 2, assuming that a diammonium salt was ana- 
lyzed (which corresponds to the free acid plus about 
8% (w/w) NHa). 
The nature of constituent A was further studied 
by mass pectrometry. Since the sample was pure by 
high-performance liquid chromatography (fig.1) it 
was introduced on a direct inlet probe after methyla- 
tion and silylation. The mass spectrum (fig3A) 
showed fragments typical for methyl ester TMS ether 
coo- 0 
0 
;-NH-CH,-COO- 
Glucuronic Acid o-OH-Genroic Acid Glycinr 
Fig.3B. Structure of compound 7c. 
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ing middle molecule fractions are released from 
homogenates and slices of liver but not from muscle, 
kidney and brain 1201. This fits with the assumption 
that the new compound is formed in the liver. 
A prerequisite for the accumulation of middle 
molecule compounds seems to be substantially 
reduced glomerular filtration (<12 ml/min) [ 2 11. 
Other factors also appear important since patients 
with the same degree of reduced renal function accu- 
mulate the compound in different amounts. Indepen 
dent of these variations, however, fraction 7c, the 
major middle molecule in some patients, has now 
been shown to be a double conjugate. 
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